Skip to main
ISRG

Intuitive Surgical (ISRG) Stock Forecast & Price Target

Intuitive Surgical (ISRG) Analyst Ratings

Based on 18 analyst ratings
Buy
Strong Buy 39%
Buy 39%
Hold 17%
Sell 0%
Strong Sell 6%

Bulls say

Intuitive Surgical has demonstrated robust operational growth, evidenced by approximately 13% year-over-year procedure growth, which has now increased by 90 basis points mainly due to strong performance in the US market. The company also recorded a notable 35% year-over-year growth in da Vinci after-hours procedures, alongside a 3% increase in US utilization rates. Furthermore, the improved average selling prices (ASPs) for systems reflect the company's strong market position and increasing demand for its innovative robotic surgical solutions.

Bears say

The outlook on Intuitive Surgical's stock is negatively impacted by several key financial indicators, including anticipated downward pressure on average selling prices (ASPs) for both systems and instruments, largely influenced by a decline in bariatric procedures and an increase in cholecystectomy cases. Additionally, while the adoption of the da Vinci 5 (Dv5) system is pivotal for overall system growth, the contributions to instruments and accessories revenue appear less robust, highlighting a reliance on procedural growth that poses risks to revenue stability. Furthermore, slower-than-expected growth in international markets like Japan and challenges in capital placements signal a potentially more difficult environment for the company's financial performance moving forward.

Intuitive Surgical (ISRG) has been analyzed by 18 analysts, with a consensus rating of Buy. 39% of analysts recommend a Strong Buy, 39% recommend Buy, 17% suggest Holding, 0% advise Selling, and 6% predict a Strong Sell.

This aggregate rating is based on analysts' research of Intuitive Surgical and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Intuitive Surgical (ISRG) Forecast

Analysts have given Intuitive Surgical (ISRG) a Buy based on their latest research and market trends.

According to 18 analysts, Intuitive Surgical (ISRG) has a Buy consensus rating as of Apr 16, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $598.89, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $598.89, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Intuitive Surgical (ISRG)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.